License Agreement grants Sagimet a global, exclusive license to innovative forms of resmetirom active pharmaceutical ingredient (API) developed by TAPI and covered by TAPI patent applications ...

Montara’s BrainOnly platform is designed to prevent peripheral side effects and concentrate neurological drugs’ activity in the brain via two-drug combination therapies, comprising its ...

The combination of denifanstat and resmetirom was generally well-tolerated Pharmacokinetic (PK) results support further development of the combination A Phase 2 trial ...

TIOBE Index for December 2025: Top 10 Most Popular Programming Languages Your email has been sent December’s TIOBE Index lands with a quieter top tier but a livelier shuffle just beneath it. The main ...

Amphastar Pharmaceuticals remains a Hold as flat growth, margin pressure, and increased marketing spend cloud its outlook. AMPH's revenue is propped up by BAQSIMI and PRIMATENE, while legacy generics ...